This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. Highlights • Higher accuracy of Alzheimer diagnosis system improves earlier diagnosis chances • Physical activity offers substantial resistance to progression of Alzheimer's disease • Ability to classify and log activities can help physicians and Alzheimer's Patients • Machine based activity monitoring offers improved Alzheimer's patient privacy
In this paper, we propose a novel framework for structural magnetic resonance image (sMRI) classification of Alzheimer's disease (AD) with data combination, outlier removal, and entropy-based data selection using AlexNet. In order to overcome problems of conventional classical machine learning methods, the AlexNet classifier, with a deep learning architecture, was employed for training and classification. A data permutation scheme including slice integration, outlier removal, and entropy-based sMRI slice selection is proposed to utilize the benefits of AlexNet. Experimental results show that the proposed framework can effectively utilize the AlexNet with the proposed data permutation scheme by significantly improving overall classification accuracies for AD classification. The proposed method achieves 95.35% and 98.74% classification accuracies on the OASIS and ADNI datasets, respectively, for the binary classification of AD and Normal Control (NC), and also achieves 98.06% accuracy for the ternary classification of AD, NC, and Mild Cognitive Impairment (MCI) on the ADNI dataset. The proposed method can attain significantly improved accuracy of up to 18.15%, compared to previously developed methods.
Recent advancements in the image capturing techniques and post processing software generate High Dynamic Range (HDR) images. Such images retain maximum information of the scene by capturing more realistic visual contents, which are often missed in traditional image capturing techniques. In this regard, tone mapping operators (TMOs) play a significant role in displaying HDR image contents on a traditional Low Dynamic Range (LDR) display. These operators tend to introduce artifacts in the original HDR image to change its brightness and contrast in such a way that it can destroy the important textures and information of the image. The assessment of these TMOs is a challenging topic to select best the best technique considering different perceptual and quality dimensions. In this paper, we propose to compare TMOs through their impact on visual behavior in comparison with HDR condition. This study is the first of its kind to utilize hidden markov model (HMM) as a similarity measure to evaluate perceived quality of TMO. The findings suggest that the proposed HMM-based method which emphasizes on temporal information produce better evaluation metric than the traditional approaches which are based only on visual spatial information.
Visual attention has been shown as a good proxy for QoE, revealing specific visual patterns considering content, system and contextual aspects of a multimedia applications. In this paper, we propose a novel approach based on hidden markov models to analyze visual scanpaths in an image memorability task. This new method ensures the consideration of both temporal and idiosyncrasic aspects of visual behavior. The study shows promising results for the use of indirect measures for the personalization of QoE assessment and prediction.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.